These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 6766119)

  • 1. Determination of antithrombin III activities by different methods in diabetic patients.
    Gandolfo GM; De Angelis A; Torresi MV
    Haemostasis; 1980; 9(1):15-9. PubMed ID: 6766119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antithrombin III, heparin cofactor and antifactor Xa in relation to age, sex and pathological condition.
    Panicucci F; Sagripanti A; Conte B; Pinori E; Vispi M; Lecchini L
    Haemostasis; 1980; 9(5):297-302. PubMed ID: 7409613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of hyperglycaemia-induced alterations of antithrombin III and factor X activation in the thrombin hyperactivity of diabetes mellitus.
    Ceriello A; Quatraro A; Marchi E; Barbanti M; Dello Russo P; Lefebvre P; Giugliano D
    Diabet Med; 1990 May; 7(4):343-8. PubMed ID: 2140088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antithrombin III activity and diabetes mellitus in the Ivory Coast population.
    Blavy G; N'Guessan R
    Nouv Rev Fr Hematol (1978); 1992; 34(4):315-6. PubMed ID: 1333072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antithrombin III in the Senegalese diabetic].
    Thiam D; Belem WC; Ndiaye MF; Diakhate L; Sow AM
    Dakar Med; 1990; 35(2):193-7. PubMed ID: 2135794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antithrombin III and factor Xa inhibitor in atherosclerosis.
    Marra R; Pagano L; De Stefano V; Bizzi B
    Haemostasis; 1983; 13(4):209-13. PubMed ID: 6618288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of oral anticoagulant treatment on plasma and serum antithrombin III: a study on 172 patients at different levels of anticoagulation.
    De Stefano V; Leone G; De Martini D; Di Donfrancesco A; Accorrà F; Bizzi B
    Haemostasis; 1987; 17(4):195-200. PubMed ID: 3114102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abnormal antithrombin III (antithrombin III "Budapest") as a cause of a familial thrombophilia.
    Sas G; Blaskó G; Bánhegyi D; Jákó J; Pálos LA
    Thromb Diath Haemorrh; 1974 Sep; 32(1):105-15. PubMed ID: 4454033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of trimethoprim-sulfamethoxazole on blood insulin and glucose concentrations of diabetics.
    Mihic M; Mautner LS; Feness JZ; Grant K
    Can Med Assoc J; 1975 Jun; 112(13 Spec No):80-2. PubMed ID: 1137831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Preliminary observations on the behavior of immunoglobulins in diabetics treated by different methods].
    Bruno A; Innocenti M; Pasquino M; Pugliese F; Zola P
    Minerva Med; 1976 Oct; 67(50):3255-60. PubMed ID: 995284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GAGs-potentiated inhibition of thrombin, factor Xa and plasmin in plasma and in a purified system containing antithrombin III - correlation with total charge density.
    Cofrancesco E; Vigo A; Pogliani EM
    Thromb Haemost; 1981 Dec; 46(4):749-51. PubMed ID: 6460339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of continuous low-dose intravenous heparin administered during operation on postoperative measurements of antithrombin III and antifactor Xa.
    Jennings SA; Heather BP; Greenhalgh RM
    Surgery; 1984 Sep; 96(3):550-5. PubMed ID: 6474360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Only minor changes in thrombin generation of children and adolescents with type 1 diabetes mellitus - A case-control study.
    Cimenti C; Schlagenhauf A; Leschnik B; Fröhlich-Reiterer E; Jasser-Nitsche H; Haidl H; Suppan E; Weinhandl G; Leberl M; Borkenstein M; Muntean WE
    Thromb Res; 2016 Dec; 148():45-49. PubMed ID: 27776253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Practical considerations on the measurement of low molecular weight heparin anti-Xa activity.
    Aiach M; Roncato M
    Semin Thromb Hemost; 1985 Apr; 11(2):108-11. PubMed ID: 4035362
    [No Abstract]   [Full Text] [Related]  

  • 15. Antithrombin III deficiency in diabetes mellitus: influence on vascular degenerative complications.
    Monnier L; Follea G; Mirouze J
    Horm Metab Res; 1978 Nov; 10(6):470-3. PubMed ID: 744566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Away with the needle. Noninvasive administration routes for insulin: improved quality of life for diabetics?].
    Simon M; Kissel T
    Pharm Unserer Zeit; 2001; 30(2):136-41. PubMed ID: 11279984
    [No Abstract]   [Full Text] [Related]  

  • 17. An antithrombin III assay based on factor Xa inhibition provides a more reliable test to identify congenital antithrombin III deficiency than an assay based on thrombin inhibition.
    Demers C; Henderson P; Blajchman MA; Wells MJ; Mitchell L; Johnston M; Ofosu FA; Fernandez-Rachubinski F; Andrew M; Hirsh J
    Thromb Haemost; 1993 Mar; 69(3):231-5. PubMed ID: 8470046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prothrombotic and prethrombotic markers in obese diabetic and non-diabetic subjects].
    Ferlito S; Di Mauro V; Palermo A; Mazzone D; Condorelli M; Papalia D
    Minerva Cardioangiol; 1991; 39(1-2):21-8. PubMed ID: 1830376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Antithrombin III: reference values found with a chromogenic substrate (chromozym TH) (author's transl)].
    Hesse R; Tritschler W; Castelfranchi G; Bablok W
    Blut; 1981 Apr; 42(4):227-34. PubMed ID: 7225580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Insulin therapy in 1970 and various reflections on the oral treatment of diabetes].
    Deuil R
    Acquis Med Recent; 1970; ():65-81. PubMed ID: 5526183
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.